Last updated on February 2018

Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication


Brief description of study

This study is designed to determine whether LLG783 displays the clinical safety and efficacy profile, after multiple i.v. doses, to support further development in patients with PAD and intermittent claudication.

Clinical Study Identifier: NCT03194776

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Jacksonville, FL United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Columbus, OH United States
  Connect »